Playback speed
10 seconds
SGO 2024 Insights: "RUBY Part 1 & Part 2 Trial - Dostarlimab + Chemo for Primary Advanced/Recurrent Endometrial Cancer & PARPi Maintenance in Patients Receiving Dostarlimab + Chemo"
By
Insights from 2024 SGO Annual Meeting
FEATURING
Mansoor Raza Mirza
By
Insights from 2024 SGO Annual Meeting
FEATURING
Mansoor Raza Mirza
185 views
April 9, 2024
Login to view comments.
Click here to Login